Neutrophil, Lymphocyte and Platelet as a Predictor for AKI and Mortality

Sponsor
Seoul National University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02916043
Collaborator
(none)
1,099
1
7
156.3

Study Details

Study Description

Brief Summary

Cell-count related risk factors for acute kidney injury after cardiovascular surgery have been reported. The authors attempted to investigate whether the perioperative cell counts of neutrophil, lymphocyte, platelet are associated with the postoperative acute kidney injury and long-term mortality after cardiovascular surgery using cardiopulmonary bypass.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Cardiovascular surgery with cardiopulmonary bypass

Detailed Description

Acute kidney injury (AKI) after cardiovascular surgery remains a serious complication associated with increased mortality for up to 10 years. The incidence of AKI after cardiovascular surgery is as high as 55% and the incidence of renal replacement therapy (RRT) to be up to 8 %.

Cell-count related risk factors for acute kidney injury after cardiovascular surgery have been reported. The authors attempted to investigate whether the perioperative cell counts of neutrophil, lymphocyte, platelet are associated with the postoperative acute kidney injury and long-term mortality after cardiovascular surgery using cardiopulmonary bypass.

Study Design

Study Type:
Observational
Actual Enrollment :
1099 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Risk Factor of Acute Kidney Injury After Open Heart Surgery With Cardiopulmonary Bypass
Study Start Date :
Apr 1, 2016
Actual Primary Completion Date :
Nov 1, 2016
Actual Study Completion Date :
Nov 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Cardiovascular surgery with cardiopulmonary bypass

Cardiovascular surgery with cardiopulmonary bypass

Procedure: Cardiovascular surgery with cardiopulmonary bypass
Patients who underwent cardiovascular surgery including valve replacement or thoracic aortic surgery with cardiopulmonary bypass

Outcome Measures

Primary Outcome Measures

  1. Acute kidney injury [postoperative day seven]

    acute kidney injury during postoperative seven days defined by Kidney Disease Improving Global Outcomes (KDIGO) criteria

Secondary Outcome Measures

  1. All-cause mortality [postoperative seven years]

    all-cause mortality after cardiovascular surgery after postoperative seven years

Other Outcome Measures

  1. Postoperative length of hospital stay [postoperative two month]

    postoperative length of hospital stay

  2. Postoperative length of ICU stay [postoperative two months]

    postoperative length of ICU stay during postoperative two months

  3. Postoperative incidence of complications [postoperative two months]

    postoperative incidences of surgery-related complications during hospital stay

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients who underwent cardiovascular surgeries with cardiopulmonary bypass (CPB), including valve replacement and surgery on the thoracic aorta at the Seoul National University Hospital between 2007 and 2015
Exclusion Criteria:
  • Missing preoperative serum creatinine (sCr) values

  • Missing preoperative platelet, neutrophil and lymphocyte counts

  • Patients who underwent preoperative hemodialysis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Hospital Seoul Korea, Republic of 03080

Sponsors and Collaborators

  • Seoul National University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Won Ho Kim, MD, Clinical Associate Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT02916043
Other Study ID Numbers:
  • 1604-038-753
First Posted:
Sep 27, 2016
Last Update Posted:
Nov 15, 2016
Last Verified:
Sep 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Won Ho Kim, MD, Clinical Associate Professor, Seoul National University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 15, 2016